drugset
drugset / Trial / NCT00131755

Efficacy of Diazoxide in Type 1 Diabetes

NCT00131755 ↗

Phase 4 Completed 40 enrolled Grill, Valdemar, M.D.
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to find out if Diazoxide can partly retain insulin production in newly diagnosed type 1 diabetes patients.

Timeline

Start
2005-02
Primary completion
2008-08
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Diazoxide Unknown — —

Indications

type 1 diabetes mellitus